Keyphrases
Crohn's Disease
68%
Inflammatory Bowel Disease
43%
Bowel Surgery
42%
Early Surgery
40%
Clinical Reports
32%
Postoperative Recurrence
32%
Elevated Liver Enzymes
32%
Intravenous Immunoglobulin (IVIg)
32%
North America
32%
Pediatric Crohn's Disease
32%
Therapeutic Management
32%
Peripheral Blood
32%
Disease Treatment
32%
Liver Disease
32%
Very Early-onset Inflammatory Bowel Disease
32%
Immune Globulin
32%
Clinical Presentation
32%
Normal children
32%
Kawasaki Disease
32%
Cytokine Modulation
32%
Penetrating Disease
26%
Early Use
23%
Very Early Onset
21%
Working Diagnosis
20%
Ulcerative Colitis
19%
Disease-associated
19%
Interleukin-6
18%
Disease Progression
18%
Disease Activity
16%
Pediatric Inflammatory Bowel Disease
15%
Stricturing Disease
13%
Stricture
12%
Pediatric Patients
12%
Interleukin-6 Receptor (IL-6R)
10%
5-year-old
10%
Mild Disease
10%
Corticosteroids
10%
Inception Cohort
10%
Alanine Aminotransferase
9%
Surgery Risk
8%
Inflammatory Bowel Disease Unclassified
8%
Postoperative Management
8%
Initial Surgery
8%
Interleukin-8
8%
Refractory Disease
8%
Clinical Recurrence
8%
Monitoring Strategy
8%
Symptom Resolution
8%
Prevention Strategies
8%
Rapid Resolution
8%
Medicine and Dentistry
Crohn's Disease
100%
Inflammatory Bowel Disease
64%
Diseases
46%
Pediatrics
42%
Recurrent Disease
32%
Liver Disease
32%
Therapeutic Management
32%
Liver Enzyme
32%
Disease Exacerbation
18%
Ulcerative Colitis
16%
Disease Activity
16%
Patient with Crohn's Disease
13%
Biological Product
13%
Pediatrics Patient
11%
Immunomodulating Agent
10%
Disease
10%
Alanine Aminotransferase
8%
Abscess Drainage
6%
Strictureplasty
6%
Sex Diagnosis
6%
Fistulotomy
6%
Colon
5%
Autoimmune Hepatitis
5%
Primary Sclerosing Cholangitis
5%
Mesalazine
5%
Colon Disease
5%
Mercaptopurine
5%
Methotrexate
5%
Overlap Syndrome
5%
Immunology and Microbiology
Inflammatory Bowel Disease
32%
Cytokine
32%
Crohn's Disease
32%
Intravenous Immunoglobulin
32%
Kawasaki Disease
32%
Interleukin 6
27%
Ulcerative Colitis
16%
Immunomodulating Drugs
10%
Tumor Necrosis Factor
7%
Colon
5%
Methotrexate
5%